This finding is consistent with our cancer patient population that receives a high level of antibiotic treatment (48) and coincides with the finding that previous antibiotic exposure has been identified as a risk factor for non-CP-CRE relative to CPE in other studies (7). The gene discussed is CP; the disease is cancer.